Our novel Chimeric Antigen Receptor (CAR) technology platform consists of several key services including CAR construction, pseudoviral particles production and stable transduction, meanwhile we also offer a series of high quality functional analysis, such as the genomic integration test, CAR expression test, cytokine release test, proliferation test and cytotoxicity test, which can guarantee that our CAR products are highly effective and less toxic, so as to accelerate your project of adoptive immunotherapy without any concerns.
Ana C. Parente-Pereira, Scott Wilkie, Sjoukje J.C. van der Stegen, David M. Davies, John Maher. Use of retroviral-mediated gene transfer to deliver and test function of chimeric antigen receptors in human T-cells.
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved